As such, antibodies against catecholamine receptors able to modulate heart frequency were identified, along with auto-antibodies against angiotensin 2 receptor and endothelin in patients with POTS (Figure 3) [81]. This evidence concerns the gene AGTR2 and postural orthostatic tachycardia syndrome.